The authors investigated, in a multicenter, double-blind, randomized trial, whether diaspirin-crosslinked hemoglobin (DCLHb) could reduce the use of allogeneic blood transfusions. This is a very interesting study for several reasons. […]
The article by Jerrold Levy et al. is one of the few randomized controlled trials published on the use of hemoglobin-based oxygen-carrying (HBOC) solutions in patients. Similarly to the study […]
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.